2018 Q1 Form 10-K Financial Statement
#000114420418012321 Filed on March 01, 2018
Income Statement
Concept | 2018 Q1 | 2017 Q4 | 2017 Q3 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $990.0K | $1.100M | $850.0K |
YoY Change | 167.57% | 266.67% | 325.0% |
% of Gross Profit | |||
Research & Development | $9.439M | $5.220M | $2.000M |
YoY Change | 6996.99% | 2385.71% | 992.9% |
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $9.439M | $6.325M | $2.848M |
YoY Change | 1772.82% | 1125.78% | 643.6% |
Operating Profit | -$10.43M | -$2.848M | |
YoY Change | 1968.45% | 643.6% | |
Interest Expense | $0.00 | $80.00K | $106.0K |
YoY Change | -100.0% | -126.67% | 19.1% |
% of Operating Profit | |||
Other Income/Expense, Net | $0.00 | $82.00K | -$100.0K |
YoY Change | -100.0% | -127.42% | -37.89% |
Pretax Income | -$10.38M | -$6.240M | -$2.950M |
YoY Change | 1472.73% | 660.98% | 446.3% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$10.38M | -$6.243M | -$2.948M |
YoY Change | 1469.89% | 666.01% | 441.91% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$1.028M | -$624.6K | -$295.9K |
COMMON SHARES | |||
Basic Shares Outstanding | 10.28M shares | 10.27M shares | 10.04M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2018 Q1 | 2017 Q4 | 2017 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $14.96M | $21.78M | $26.05M |
YoY Change | 10790.0% | 86733.33% | |
Cash & Equivalents | $14.96M | $11.78M | $16.05M |
Short-Term Investments | $0.00 | $10.00M | $10.00M |
Other Short-Term Assets | $310.0K | $390.0K | $130.0K |
YoY Change | 34.78% | 333.33% | |
Inventory | |||
Prepaid Expenses | $126.0K | ||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $15.27M | $22.17M | $26.18M |
YoY Change | 6539.13% | 10985.0% | 43533.33% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $3.000K | $0.00 | -$4.000K |
YoY Change | -25.0% | -100.0% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $15.27M | $22.17M | $26.18M |
Total Long-Term Assets | $3.000K | $0.00 | -$4.000K |
Total Assets | $15.27M | $22.17M | $26.18M |
YoY Change | 6426.92% | 11153.81% | 43526.67% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.909M | $1.545M | $1.910M |
YoY Change | 349.31% | 362.57% | 377.5% |
Accrued Expenses | $2.010M | $50.00K | $80.00K |
YoY Change | 1.52% | -97.14% | -94.2% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
Total Short-Term Liabilities | $5.920M | $2.790M | $1.990M |
YoY Change | -24.35% | -56.54% | -58.19% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | -100.0% |
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | -100.0% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $5.920M | $2.790M | $1.990M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $5.920M | $2.790M | $1.990M |
YoY Change | -35.22% | -66.96% | -73.64% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$31.04M | -$20.66M | -$14.42M |
YoY Change | 242.43% | 145.88% | |
Common Stock | $40.39M | $38.94M | $38.60M |
YoY Change | 25144.38% | 36633.96% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $9.353M | $19.38M | $24.19M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $15.27M | $22.17M | $26.18M |
YoY Change | 6426.92% | 11153.81% | 43526.67% |
Cashflow Statement
Concept | 2018 Q1 | 2017 Q4 | 2017 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$10.38M | -$6.243M | -$2.948M |
YoY Change | 1469.89% | 666.01% | 441.91% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$6.819M | -$4.270M | -$1.870M |
YoY Change | 19955.88% | 6000.0% | 325.0% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | ||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $10.00M | $0.00 | -$10.00M |
YoY Change | |||
Cash From Investing Activities | $10.00M | $0.00 | -$10.00M |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $0.00 | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 0.000 | -6.750M |
YoY Change | -100.0% | -100.0% | -1600.0% |
NET CHANGE | |||
Cash From Operating Activities | -6.819M | -4.270M | -1.870M |
Cash From Investing Activities | 10.00M | 0.000 | -10.00M |
Cash From Financing Activities | 0.000 | 0.000 | -6.750M |
Net Change In Cash | 3.181M | -4.270M | -18.62M |
YoY Change | -1714.72% | -2611.76% | -186300.0% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$6.819M | -$4.270M | -$1.870M |
Capital Expenditures | $0.00 | ||
Free Cash Flow | -$4.270M | ||
YoY Change | 6000.0% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2017 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2017 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2017 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2017 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2017Q2 | dei |
Entity Public Float
EntityPublicFloat
|
50811757 | USD |
CY2017 | dei |
Trading Symbol
TradingSymbol
|
ATXI | |
CY2018Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
10277083 | shares |
CY2016 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
57000 | USD |
CY2017 | atxi |
Accrued Interest Related Party
AccruedInterestRelatedParty
|
-46000 | USD |
CY2016 | atxi |
Accrued Interest Related Party
AccruedInterestRelatedParty
|
181000 | USD |
CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6802000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1632000 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11782000 | USD |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
197000 | USD |
CY2017Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
10000000 | USD |
CY2016Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
0 | USD |
CY2017Q4 | atxi |
Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
|
53000 | USD |
CY2016Q4 | atxi |
Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
|
1348000 | USD |
CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1331000 | USD |
CY2016 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
997000 | USD |
CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2377000 | USD |
CY2016 | us-gaap |
Interest Expense
InterestExpense
|
420000 | USD |
CY2016 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
192000 | USD |
CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3177000 | USD |
CY2016 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.11 | |
CY2016 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2860526 | shares |
CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6698000 | USD |
CY2017 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3620000 | USD |
CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-11421000 | USD |
CY2017 | us-gaap |
Interest Expense
InterestExpense
|
294000 | USD |
CY2017 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
81000 | USD |
CY2017 | atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
99000 | USD |
CY2017 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
451000 | USD |
CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12258000 | USD |
CY2016 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
0 | USD |
CY2017 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
88000 | USD |
CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
604000 | USD |
CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
28000 | USD |
CY2017 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
174000 | USD |
CY2016 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
123000 | USD |
CY2017 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
2231000 | USD |
CY2016 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
15000 | USD |
CY2017 | us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
337000 | USD |
CY2016 | us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
829000 | USD |
CY2017 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-57000 | USD |
CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
28387000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1815000 | USD |
CY2017 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
11585000 | USD |
CY2016 | us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
183000 | USD |
CY2017 | us-gaap |
Interest Paid Net
InterestPaidNet
|
303000 | USD |
CY2016 | us-gaap |
Interest Paid Net
InterestPaidNet
|
183000 | USD |
CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
388000 | USD |
CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
0 | USD |
CY2017 | us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
3715000 | USD |
CY2016 | us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
0 | USD |
CY2017 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
37950000 | USD |
CY2016 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
CY2017 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
1000000 | USD |
CY2016 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
0 | USD |
CY2017 | atxi |
Warrants Issued
WarrantsIssued
|
750000 | USD |
CY2016 | atxi |
Warrants Issued
WarrantsIssued
|
0 | USD |
CY2017 | atxi |
Extinguishment Of Fortress Compensation Accrual
ExtinguishmentOfFortressCompensationAccrual
|
632000 | USD |
CY2016 | atxi |
Extinguishment Of Fortress Compensation Accrual
ExtinguishmentOfFortressCompensationAccrual
|
0 | USD |
CY2017 | atxi |
Interest On Fortress Note On Modification
InterestOnFortressNoteOnModification
|
300000 | USD |
CY2016 | atxi |
Interest On Fortress Note On Modification
InterestOnFortressNoteOnModification
|
0 | USD |
CY2017 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
200000 | USD |
CY2016 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD |
CY2017 | atxi |
Change Fair Value Of Convertible Note Warrents
ChangeFairValueOfConvertibleNoteWarrents
|
15000 | USD |
CY2016 | atxi |
Change Fair Value Of Convertible Note Warrents
ChangeFairValueOfConvertibleNoteWarrents
|
0 | USD |
CY2017 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
10000000 | USD |
CY2016 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
0 | USD |
CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-10000000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD |
CY2017 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
3000000 | USD |
CY2016 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
CY2017 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
0 | USD |
CY2016 | us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
1000 | USD |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14000 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5226000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
29000 | USD | |
atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
0 | USD | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
73000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
491000 | USD | |
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
511000 | USD | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD | |
atxi |
Accrued Interest Related Party
AccruedInterestRelatedParty
|
165000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-895000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3909000 | USD | |
us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
14000 | USD | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
60000 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
0 | USD | |
us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
0 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD | |
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
0 | USD | |
atxi |
Warrants Issued
WarrantsIssued
|
0 | USD | |
atxi |
Extinguishment Of Fortress Compensation Accrual
ExtinguishmentOfFortressCompensationAccrual
|
0 | USD | |
atxi |
Interest On Fortress Note On Modification
InterestOnFortressNoteOnModification
|
0 | USD | |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD | |
atxi |
Change Fair Value Of Convertible Note Warrents
ChangeFairValueOfConvertibleNoteWarrents
|
0 | USD | |
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
0 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3000000 | USD | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD | |
us-gaap |
Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
|
0 | USD | |
CY2015Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
0 | USD |
CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
300000 | USD |
CY2017Q3 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
5000000 | USD |
CY2016Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
250000 | shares |
CY2016Q3 | us-gaap |
Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
|
0.025 | pure |
CY2015Q4 | us-gaap |
Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
|
3000000 | USD |
CY2017 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
200000 | USD |
CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.8 | pure |
CY2017Q3 | us-gaap |
Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
|
3500000 | USD |
CY2017Q3 | us-gaap |
Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
|
100000 | USD |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q2 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
166666 | shares |
CY2017Q2 | us-gaap |
Share Price
SharePrice
|
6.00 | |
CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
20000 | shares |
CY2017Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
6.29 | |
CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0183 | pure |
CY2017Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
0 | shares |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
20000 | shares |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
20000 | shares |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
6.29 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.29 | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P4Y7M17D | |
CY2017Q4 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
0 | USD |
CY2016Q4 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
300000 | USD |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2017Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
388000 | USD |
CY2016Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
0 | USD |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
10265083 | shares |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
10265083 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3257936 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3257936 | shares |
CY2017Q4 | atxi |
Common Stock Shares Issuable
CommonStockSharesIssuable
|
273837 | shares |
CY2016Q4 | atxi |
Common Stock Shares Issuable
CommonStockSharesIssuable
|
83532 | shares |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
961000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
842000 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4843000 | USD | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
0 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
215000 | USD | |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
168000 | USD | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-1.93 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2702403 | shares | |
CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 3.3pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0px; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong><i>Use of Estimates</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 3.3pt; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong><i> </i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2017 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
1103000 | USD |
CY2016 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
49000 | USD |
us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
3040000 | USD | |
CY2017 | us-gaap |
Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0px; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0px; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong><i>Valuation of Warrant Related to NSC Note</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0px; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">In accordance with ASC 815 <i>Derivatives and Hedging</i>, the Company classified the fair value of the warrant (“Contingently Issuable Warrants”) that it may be obligated to issue to National Securities, Inc. (“NSC”), in connection with the transfer on October 31, 2015 of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.0</font> million of indebtedness to NSC, as a derivative liability as there was a potential that the Company would not have a sufficient number of authorized common shares available to settle this instrument. The Company valued these Contingently Issuable Warrants using a Black-Scholes model and used estimates for an expected dividend yield, a risk-free interest rate, and expected volatility together with management’s estimate of the probability of issuance of the Contingently Issuable Warrants. At each reporting period, as long as the Contingently Issuable Warrants were potentially issuable and there was a potential for an insufficient number of authorized shares available to settle the Contingently Issuable Warrants, the Contingently Issuable Warrants had to be revalued and any difference from the previous valuation date would be recognized as a change in fair value in the Company’s statement of operations. On June 26, 2017, the warrants were issued (See Note 9).</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
100000 | USD | |
CY2017 | atxi |
Stock Issuance Common Stock Issuable During Period Value
StockIssuanceCommonStockIssuableDuringPeriodValue
|
1103000 | USD |
CY2017 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
34235000 | USD |
CY2016 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
0 | USD |
us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
3000000 | USD | |
CY2017 | atxi |
Stock Issued During Period Conversion Of Msa Fees Into Common Value
StockIssuedDuringPeriodConversionOfMsaFeesIntoCommonValue
|
1000000 | USD |
CY2017 | atxi |
Stock Issued During Period Issuance Of Warrants Under Nsc Note
StockIssuedDuringPeriodIssuanceOfWarrantsUnderNscNote
|
750000 | USD |
CY2017 | atxi |
Share Issued During Period Valueon Exercise Of Warrants
ShareIssuedDuringPeriodValueonExerciseOfWarrants
|
0 | USD |
CY2017 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
299000 | USD |
CY2017 | atxi |
Change In Fair Value Of Convertible Notes Warrants
ChangeInFairValueOfConvertibleNotesWarrants
|
15000 | USD |
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1545000 | USD |
CY2016Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
334000 | USD |
CY2017Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
215000 | USD |
CY2016Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
0 | USD |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
977000 | USD |
CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
172000 | USD |
atxi |
Stock Issued During Period Value Issuable To Parent New Issues
StockIssuedDuringPeriodValueIssuableToParentNewIssues
|
0 | USD | |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
22000 | USD | |
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
29000 | USD | |
atxi |
Stock Issuance Common Stock Issuable During Period Value
StockIssuanceCommonStockIssuableDuringPeriodValue
|
40000 | USD | |
CY2016 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
5000 | USD |
CY2016 | atxi |
Common Stock Converted To Preferred Shares Value
CommonStockConvertedToPreferredSharesValue
|
0 | USD |
CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
28000 | USD |
CY2016 | atxi |
Stock Issuance Common Stock Issuable During Period Value
StockIssuanceCommonStockIssuableDuringPeriodValue
|
49000 | USD |
CY2016 | us-gaap |
Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
|
18000 | USD |
CY2017 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
604000 | USD |
CY2017 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
948000 | USD |
CY2017 | atxi |
Modification To Interest On Fortress Note
ModificationToInterestOnFortressNote
|
300000 | USD |
CY2017 | us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
632000 | USD |
CY2017 | atxi |
Agreement Description Terms
AgreementDescriptionTerms
|
(i) issue annually to Fortress, on the anniversary date of the Founders Agreement, shares of common stock equal to two and one half percent (2.5%) of the fully-diluted outstanding equity of Avenue at the time of issuance; (ii) pay an equity fee in shares of Avenue common stock, payable within five (5) business days of the closing of any equity or debt financing for Avenue or any of its respective subsidiaries that occurs after the effective date of the Founders Agreement and ending on the date when Fortress no longer has majority voting control in Avenues voting equity, equal to two and one half percent (2.5%) of the gross amount of any such equity or debt financing; and (iii) pay a cash fee equal to four and one half percent (4.5%) of Avenues annual net sales, payable on an annual basis, within ninety (90) days of the end of each calendar year. In the event of a change in control (as it is defined in the Founders Agreement), Fortress will be paid a one-time change in control fee equal to five (5x) times the product of (i) net sales for the twelve (12) months immediately preceding the change in control and (ii) four and one-half percent (4.5%). | |
CY2017 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD |
CY2016 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD |
CY2017 | us-gaap |
Other Research And Development Expense
OtherResearchAndDevelopmentExpense
|
0 | USD |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
22000 | USD | |
CY2017 | atxi |
Common Stock Issuable For Founder Agreement
CommonStockIssuableForFounderAgreement
|
1103000 | USD |
CY2016 | atxi |
Common Stock Issuable For Founder Agreement
CommonStockIssuableForFounderAgreement
|
49000 | USD |
atxi |
Common Stock Issuable For Founder Agreement
CommonStockIssuableForFounderAgreement
|
40000 | USD | |
CY2017 | atxi |
Issuance Of Common Shares For Founders Agreement
IssuanceOfCommonSharesForFoundersAgreement
|
948000 | USD |
CY2016 | atxi |
Issuance Of Common Shares For Founders Agreement
IssuanceOfCommonSharesForFoundersAgreement
|
5000 | USD |
atxi |
Issuance Of Common Shares For Founders Agreement
IssuanceOfCommonSharesForFoundersAgreement
|
0 | USD | |
CY2017 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
0 | USD |
CY2016 | us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
58000 | USD |
us-gaap |
Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
|
0 | USD | |
CY2017 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
0 | USD |
CY2016 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
12000 | USD |
us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
0 | USD | |
CY2017 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
0 | USD |
CY2016 | us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
0 | USD |
us-gaap |
Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
|
3000000 | USD | |
CY2017 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD |
CY2016 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
200000 | USD |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | USD | |
CY2017 | us-gaap |
Payments Of Loan Costs
PaymentsOfLoanCosts
|
0 | USD |
CY2016 | us-gaap |
Payments Of Loan Costs
PaymentsOfLoanCosts
|
58000 | USD |
us-gaap |
Payments Of Loan Costs
PaymentsOfLoanCosts
|
0 | USD | |
CY2017 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
CY2016 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | USD |
us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
256000 | USD | |
CY2017 | us-gaap |
Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
|
0 | USD |
CY2016 | us-gaap |
Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
|
0 | USD |
us-gaap |
Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
|
3000000 | USD | |
CY2017 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
637000 | USD |
CY2016 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1673000 | USD |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1165000 | USD | |
CY2017 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
3485000 | USD |
CY2016 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
0 | USD |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
0 | USD | |
CY2017 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
0 | USD |
CY2016 | us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
0 | USD |
us-gaap |
Liabilities Assumed1
LiabilitiesAssumed1
|
114000 | USD | |
CY2017 | atxi |
Retirement Of Common Shares
RetirementOfCommonShares
|
0 | USD |
CY2016 | atxi |
Retirement Of Common Shares
RetirementOfCommonShares
|
18000 | USD |
atxi |
Retirement Of Common Shares
RetirementOfCommonShares
|
0 | USD | |
CY2017 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
CY2016 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
us-gaap |
Stock Issued1
StockIssued1
|
1000 | USD | |
CY2017 | atxi |
Service Agreement Expenses
ServiceAgreementExpenses
|
500000 | USD |
CY2016 | atxi |
Service Agreement Expenses
ServiceAgreementExpenses
|
500000 | USD |
CY2015 | atxi |
Service Agreement Expenses
ServiceAgreementExpenses
|
400000 | USD |
CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
504000 | USD |
CY2017Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
1744000 | USD |
CY2017Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
2848000 | USD |
CY2017Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
6325000 | USD |
CY2017Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-157000 | USD |
CY2017Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-662000 | USD |
CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-661000 | USD |
CY2017Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-100000 | USD |
CY2017Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
82000 | USD |
CY2016 | atxi |
Effective Income Tax Rate Reconciliation Change In Enacted Federal Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedFederalTaxRatePercent
|
0 | pure |
CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2406000 | USD |
CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2948000 | USD |
CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6243000 | USD |
CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.07 | |
CY2017Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.70 | |
CY2017Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.30 | |
CY2017Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.63 | |
CY2016Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
840000 | USD |
CY2016Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
638000 | USD |
CY2016Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
383000 | USD |
CY2016Q4 | us-gaap |
Operating Expenses
OperatingExpenses
|
516000 | USD |
CY2016Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-207000 | USD |
CY2016Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-133000 | USD |
CY2016Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-161000 | USD |
CY2016Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-299000 | USD |
CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1047000 | USD |
CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-771000 | USD |
CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-544000 | USD |
CY2016Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-815000 | USD |
CY2016Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.13 | |
CY2016Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.28 | |
CY2016Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.19 | |
CY2016Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.27 | |
CY2017 | atxi |
Effective Income Tax Rate Reconciliation Change In Enacted State Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedStateTaxRatePercent
|
0.01 | pure |
CY2016 | atxi |
Effective Income Tax Rate Reconciliation Change In Enacted State Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedStateTaxRatePercent
|
-0.01 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.04 | pure |
CY2017 | atxi |
Effective Income Tax Rate Reconciliation Change In Enacted Federal Tax Rate Percent
EffectiveIncomeTaxRateReconciliationChangeInEnactedFederalTaxRatePercent
|
-0.2 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.35 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
0.08 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
-0.03 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
-0.01 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
|
0 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0.01 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
|
0 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.21 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.38 | pure |
CY2017 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2016 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
4220000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
2080000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
70000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
|
0 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
|
226000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
|
73000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
1064000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
|
1064000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
8000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
|
78000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
154000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
|
33000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
5742000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
3328000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
5742000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
3318000 | USD |
CY2017Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
0 | USD |
CY2016Q4 | us-gaap |
Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
|
10000 | USD |
CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
CY2017 | atxi |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Granted Contractuallterm1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingGrantedContractuallterm1
|
P5Y | |
CY2016Q3 | us-gaap |
Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
|
33333 | shares |
CY2017Q4 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
200000 | USD |
CY2017Q2 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
49748 | shares |
CY2017Q3 | us-gaap |
Share Price
SharePrice
|
1.85 | |
CY2017Q3 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
37000 | USD |
CY2017Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
6.29 | |
CY2015Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | USD |
CY2016Q4 | us-gaap |
Notes Payable
NotesPayable
|
2826000 | USD |
CY2017Q4 | us-gaap |
Notes Payable
NotesPayable
|
0 | USD |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5135000 | USD |
CY2017Q2 | atxi |
Share Based Compensation Allocation Percentage
ShareBasedCompensationAllocationPercentage
|
1 | pure |
CY2017 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
984999 | shares |
CY2016 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
524999 | shares |
us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
366666 | shares | |
CY2017Q3 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
5000000 | USD |
CY2017 | atxi |
Extend Loan Modification Reduction To Interest Expense
ExtendLoanModificationReductionToInterestExpense
|
300000 | USD |
CY2015Q4 | us-gaap |
Notes Payable
NotesPayable
|
2703000 | USD |